Thoracic oncology department

The thoracic oncology department is located on the fifth floor of the Oncology Center’s main building. The department has 30 beds. It employs 5 doctors, 9 nurses and 10 nursing assistants.

The department was established on 12 April 1978. Its founder was Oleksandr Vynnychenko.

Until 2016, the department was headed by Ihor Vynnychenko. From 2016 to 2022, it was headed by Ivan Nikitin.

Patients of the Oncology Center’s thoracic oncology department are seen in the following rooms of the outpatient follow-up department:

• No. 225: for patients with cancer of the lung, esophagus, mediastinal organs and gastric cardia;
• No. 224: bronchoscopy room;
• No. 223: for patients with head and neck cancers.

Operations performed in the Oncology Center’s thoracic oncology department

For lung tumors: atypical lung resections, lobectomies, bilobectomies, pneumonectomies, video-assisted thoracoscopy with biopsy, mediastinoscopy with biopsy of mediastinal lymph nodes.

Fine-needle aspiration biopsy (FNAB) and core needle biopsy of lung and pleural tumors under CT guidance.

For esophageal tumors: Lewis operation, gastrectomy, enterostomy.

For tumors of the cardia and stomach: Ohsawa–Garlock operations, gastrectomy.

For mediastinal tumors: mediastinoscopy with biopsy of a mediastinal lymph node (tumor), removal of mediastinal tumors.

For soft tissue tumors of the chest wall and ribs: resection of the chest wall and ribs, with reconstruction when necessary.

For tumor metastases to the lymph nodes (for diagnostic purposes): biopsy of cervical, supraclavicular and axillary lymph nodes.

For skin tumors of the head and neck: removal (or wide excision) of skin tumors with or without reconstruction.

For tumors of the oral mucosa:

• hemiresection of the tongue (with or without reconstruction);
• hemiresection of the tongue combined with resection of the floor of the mouth and/or the mandible, with reconstruction and combined with fascial-sheath neck dissection;
• ligation of the external carotid arteries;
• for tumors of the floor of the mouth: resection of the floor of the mouth with reconstruction, combined (or not) with resection of the mandible;
• for tumors of the soft palate: resection of the soft palate and tonsils;
• for tumors of the upper jaw: resection of the upper jaw;
• for extraorgan tumors of the neck: excision of neck tumors, combined (or not) with fascial-sheath neck dissection;
• for thyroid tumors: subtotal thyroid resection, thyroidectomy, combined (or not) with fascial-sheath neck dissection;
• for salivary gland tumors: extirpation of salivary glands, resection of salivary glands, removal of salivary gland tumors;
• for laryngeal tumors: tracheostomy, laryngectomy, combined (or not) with fascial-sheath neck dissection;
• for metastatic involvement of the cervical lymph nodes (in head and neck tumors): fascial-sheath neck dissection, Crile operations.

The thoracic oncology department is a site for international clinical trials and has more than 10 years of experience in conducting them.